QualityStocksNewsBreaks Archives - Page 198 of 1582

WednesdayJun 25, 2025 12:30 pm

QualityStocksNewsBreaks – FAVO Capital Inc. (FAVO) Eyes Opportunity at Crossroads of Fintech Innovation, Lending Demand

As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market. With policymakers calling for renewed focus on small business financing and digital platforms redefining borrower access, private credit firms like FAVO Capital (OTC: FAVO) are emerging as essential players in the financial ecosystem. Leveraging scalable technology, a seasoned leadership team, and a growing syndication network, FAVO is positioning for growth at the intersection of market demand and digital transformation. “At the heart of FAVO’s competitive advantage is its technology-focused lending model. The company continues to build and refine…

WednesdayJun 25, 2025 11:50 am

QualityStocksNewsBreaks – Titan Partners Group LLC Leads $200 Million Private Placement for Quantum Computing (NASDAQ: QUBT)

Titan Partners, a division of American Capital Partners, is acting as sole placement agent in a $200 million private placement for Quantum Computing Inc. (NASDAQ: QUBT), an integrated photonics and quantum optics technology company. The offering involves the sale of 14,035,089 shares of common stock to institutional investors at $14.25 per share. Quantum Computing intends to use the proceeds to accelerate commercialization, pursue strategic acquisitions, and support working capital and general corporate needs. To view the full press release, visit https://ibn.fm/uMVdV About Titan Partners Group LLC Titan Partners Group LLC (“Titan Partners”), a division of American Capital Partners, LLC (“ACP”) is…

WednesdayJun 25, 2025 9:15 am

QualityStocksNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology firm specializing in non-invasive drug screening, reported continued success in its partnership with Spjotgard, a Scandinavian distributor. The collaboration is accelerating adoption of INBS’ fingerprint-based Drug Screening System across Sweden, Norway, and Denmark, with Finland showing rising interest. The technology offers a less invasive, hygienic alternative to urine and saliva tests, delivering results in under 10 minutes and gaining traction in sectors like logistics, education, and criminal justice. Spjotgard’s growing regional presence and strategic alliances position INBS to scale further in Northern Europe. To view the full article, visit https://ibn.fm/PJPCa About Intelligent…

TuesdayJun 24, 2025 10:45 am

QualityStocksNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) to Launch Pawpa(TM) Regen Nationwide as Stem Cell-Based Canine Supplement Gains Momentum

BioAdaptives (OTC Pink: BDPT), a leader in nutraceutical and wellness innovation, will launch its proprietary canine supplement Pawpa(TM) Regen nationwide by the end of July 2025. Designed to support natural stem cell activation in aging dogs, the supplement has shown promising results in early trials, including improved energy, mobility, coat quality, and temperament. CEO James Keener emphasized the product’s unique regenerative approach using safe, naturally sourced ingredients. With strong early feedback and growing demand for holistic pet care solutions, BioAdaptives is expanding production ahead of the broader e-commerce rollout. To view the full press release, visit https://ibn.fm/Y6PRK About BioAdaptives, Inc.…

TuesdayJun 24, 2025 9:10 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch

NRx Pharmaceuticals (NASDAQ: NRXP) a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, has engaged IBN to manage its corporate communications strategy. NRx is advancing two FDA-designated therapies—NRX-100 and NRX-101—with an NDA underway for NRX-100 and additional regulatory filings in progress. The company also launched HOPE Therapeutics, a subsidiary focused on building a national psychiatric care network, with plans for a public spin-out. IBN will leverage its extensive media portfolio to expand investor awareness and outreach. To view the full press release, visit https://ibn.fm/L8kUd About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics…

TuesdayJun 24, 2025 9:00 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Announces 1-for-10 Reverse Share Split to Regain Nasdaq Compliance

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company pursuing a multi-club ownership (“MCO”) strategy in global sports, will implement a 1-for-10 reverse share split of its Class A and Class B ordinary shares effective June 26, 2025, to meet Nasdaq’s minimum bid price requirement. Following shareholder and board approval, the split will reduce the number of Class A shares from approximately 6.3 million to 633,800 and Class B shares from 17.8 million to 1.78 million, while increasing nominal share value from $0.005 to $0.05. Fractional shares will be rounded up, and no shareholder action is required. To view the…

MondayJun 23, 2025 11:30 am

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Celebrates Major Victory as Miguel Ángel Jiménez Wins PGA TOUR Champions Title with Fast Motion Shaft

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company specializing in innovative golf products, announced a major on-course win as Miguel Ángel Jiménez captured the Kaulig Companies Championship on the PGA TOUR Champions using the Newton Fast Motion shaft. This marks Jiménez’s third major championship title on the Tour and his second since switching to the Fast Motion shaft five starts ago. The win—his 17th career PGA TOUR Champions victory—cements his No. 1 ranking and underscores the shaft’s growing reputation among elite professionals. Engineered for speed and stability, the Fast Motion shaft integrates four proprietary technologies—Elongated Bend Profile, Kinetic Energy…

MondayJun 23, 2025 10:40 am

QualityStocksNewsBreaks – IBN Named Media Partner for 3rd Annual AI World Week in Washington, D.C.

IBN (InvestorBrandNetwork), a corporate communications and content distribution company with a portfolio of over 70 investor-facing brands, has been named the official media partner for the 3rd Annual AI World Week: Shaping the Future of Innovation and Investment, taking place Oct. 8, 2025, at the National Press Club in Washington, D.C. Hosted by AI World Society (AIWS) Circle in collaboration with the AI World Journal, the full-day event will bring together global experts to explore AI trends, ethics, and innovation. As media sponsor, IBN will deploy its multi-brand distribution network and advanced communications platforms to elevate visibility for the conference,…

MondayJun 23, 2025 9:20 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s Priority Voucher for NRX-100 Ketamine Formulation

NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner’s National Priority Voucher (CNPV) program, seeking accelerated review for NRX-100, its preservative-free intravenous ketamine formulation. The company believes NRX-100 meets all criteria outlined by FDA Commissioner Marty Makary, who announced the voucher program on June 17, 2025, to prioritize treatments aligned with urgent U.S. health needs—including suicidal depression and PTSD. NRx has already submitted the chemistry, manufacturing, and controls (CMC) portion of its application and received FDA feedback, placing it on track for potential accelerated review of its full New Drug Application (NDA) by late 2025. If granted,…

MondayJun 23, 2025 9:00 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Price Target Raised to $15 Following AVERSA Fentanyl Manufacturing Milestone

Nutriband (NASDAQ: NTRB) has received a new $15 price target in an updated report from Robert LeBoyer, Senior Vice President and Equity Research Analyst, Biotechnology, at Noble Capital Markets, following the successful completion of commercial manufacturing and scale-up for AVERSA Fentanyl, its abuse-deterrent transdermal patch developed in partnership with Kindeva. The report highlights this milestone as a key inflection point that enables Nutriband to initiate production of clinical supplies and proceed with its planned Investigational New Drug ("IND") application for a Phase 1 trial. The AVERSA program follows the 505(b)(2) regulatory pathway and requires only a single Phase 1 study,…

Site Search

Company Search

Category: QualityStocksNewsBreaks